New patent for Merck Sharp drug WELIREG

Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…

The post New patent for Merck Sharp drug WELIREG appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog